Segulah pockets €175m on Medstop sale
The exit to pharmaceuticals group Oriola-KD is the first by the Swedish firm’s Fund IV, a 2008 vintage now 70% invested.
20 September 2013•2 mins read
The exit to pharmaceuticals group Oriola-KD is the first by the Swedish firm’s Fund IV, a 2008 vintage now 70% invested.
